Tilray Brands (TLRY) Interest & Investment Income (2018 - 2024)
Tilray Brands' (TLRY) quarterly Interest & Investment Income came in at $12.8 million in Q2 2024, down 86.54% on a QoQ basis from $95.3 million in Q1 2023.
Tilray Brands (TLRY) Interest & Investment Income (2018 - 2024) Analysis & Trends
Tilray Brands (TLRY) has 6 years of Interest & Investment Income data on file, last reported at $12.8 million in Q2 2024.
- Quarterly Interest & Investment Income changed N/A year-over-year to $12.8 million in Q2 2024, while the trailing twelve-month figure through May 2024 was $12.8 million (down 82.93% YoY) and the FY2026 annual result came in at $6.2 million, down 45.08% from the prior year.
- Interest & Investment Income declined to $12.8 million in Q2 2024, from $95.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $95.3 million in Q1 2023 to a low of -$39.3 million in Q1 2022.
- A 4-year average of $2.1 million and a median of -$8.9 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income tumbled 289.06% — and 2023, when it soared 342.63%.
- Tracing TLRY's Interest & Investment Income over 4 years: stood at -$16.3 million in 2021, then decreased by 8.21% to -$17.6 million in 2022, then soared by 640.41% to $95.3 million in 2023, then tumbled by 86.54% to $12.8 million in 2024.
- The last three Interest & Investment Income figures came in at $12.8 million (Q2 2024), $95.3 million (Q1 2023), and -$17.6 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Tilray Brands | 509.96 Mn | 275.32 Mn | 90.52 Mn | -6.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 12.83 Mn |
| Feb 28, 2023 | 95.35 Mn |
| Nov 30, 2022 | -17.64 Mn |
| Aug 31, 2022 | -2.53 Mn |
| May 31, 2022 | -15.18 Mn |
| Feb 28, 2022 | -39.30 Mn |
| Nov 30, 2021 | -16.31 Mn |
| Aug 31, 2021 | -649,000.00 |
| Dec 31, 2019 | 207,000.00 |
| Sep 30, 2019 | 210,000.00 |
| Mar 31, 2019 | 135,000.00 |
| Sep 30, 2018 | 170,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Mar 31, 2018 | 1,000.00 |